Found 6 matching trials
A Study of Zigakibart in Adults With IgA Nephropathy
PHASE3Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham: The Kirklin Clinic
Atrasentan in Patients With IgA Nephropathy
PHASE3The ALIGN Study is a phase 3, double-blind, placebo-controlled study to com...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)
PHASE1This is a Phase 1/2 study designed to evaluate the safety and tolerability ...
Location
James R. Berenson, MD, Inc
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
PHASE3The purpose of this study is to determine if zigakibart is safe and effecti...
Location
Colorado Kidney Care Nephrology
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
PHASE1Multicenter study designed to evaluate the safety, tolerability, pharmacoki...
Location
Amicis Research Center
Open-label Safety and PK Study of BION-1301 in Japanese Healthy Subjects
PHASE1Phase 1, open-label study designed to evaluate safety, tolerability, pharma...
Location
Collaborative Neuroscience Research, LLC